Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.

M. Hennerici; M.L. Bots; I. Ford; S. Laurent; P.J. Touboul

Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.

Translated title of the contribution: Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.

M. Hennerici, M.L. Bots, I. Ford, S. Laurent, P.J. Touboul

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.
Original language	Undefined/Unknown
Pages (from-to)	175-180
Number of pages	6
Journal	Cardiovascular Drugs and Therapy
Volume	24
Publication status	Published - 2010

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Cite this

Hennerici, M., Bots, M. L., Ford, I., Laurent, S., & Touboul, P. J. (2010). Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial. Cardiovascular Drugs and Therapy, 24, 175-180.

Hennerici, M. ; Bots, M.L. ; Ford, I. et al. / Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial. In: Cardiovascular Drugs and Therapy. 2010 ; Vol. 24. pp. 175-180.

@article{a5e9fb9e0a5246d3b2ea019c6dc117b2,

title = "Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M. Hennerici and M.L. Bots and I. Ford and S. Laurent and P.J. Touboul",

year = "2010",

language = "Undefined/Unknown",

volume = "24",

pages = "175--180",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

}

Hennerici, M, Bots, ML, Ford, I, Laurent, S & Touboul, PJ 2010, 'Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.', Cardiovascular Drugs and Therapy, vol. 24, pp. 175-180.

Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial. / Hennerici, M.; Bots, M.L.; Ford, I. et al.
In: Cardiovascular Drugs and Therapy, Vol. 24, 2010, p. 175-180.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial.

AU - Hennerici, M.

AU - Bots, M.L.

AU - Ford, I.

AU - Laurent, S.

AU - Touboul, P.J.

PY - 2010

Y1 - 2010

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 0920-3206

VL - 24

SP - 175

EP - 180

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

ER -

Hennerici M, Bots ML, Ford I, Laurent S, Touboul PJ. Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischema strOke of tRansient ischeMic attack (PERFORM) trial. Cardiovascular Drugs and Therapy. 2010;24:175-180.